by Team Small News | May 31, 2025 | Cipla, Pharma
The US Food and Drug Administration (USFDA) has issued a single observation for Cipla’s Bommasandra facility, which is a pharmaceutical manufacturing plant located in Karnataka, India. The observation was made after the USFDA conducted an inspection of the... by Team Small News | May 31, 2025 | Pfizer, Pharma
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured significant presentations from major pharmaceutical companies, including Pfizer, AstraZeneca, and Daiichi Sankyo. The meeting highlighted new data on innovative cancer treatments, showcasing... by Team Small News | May 31, 2025 | Fortis, Pharma
A 68-year-old woman, Mrs. Basanti, was successfully treated for severe shoulder arthritis at Fortis Hospital Nagarbhavi in Bangalore. She had been suffering from intense pain and limited mobility in her right shoulder for over two years, which affected her daily...
by Team Small News | May 31, 2025 | Pharma, Piramal Pharma
Piramal Pharma, a leading global pharmaceutical company, has announced the expansion of its biologics manufacturing infrastructure to enhance its drug development capabilities. This strategic move is aimed at strengthening the company’s position in the... by Team Small News | May 30, 2025 | Pfizer, Pharma
Pfizer’s recent failure to gain FDA approval for its oral obesity drug, danuglipron, has raised concerns about the company’s research and development pipeline. Danuglipron was expected to be a major contributor to Pfizer’s revenue growth, but its... by Team Small News | May 30, 2025 | Natco, Pharma
Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company’s...